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Abstract 
[14C]Artemisinin was taken up by Plasmodiumfalciparum in culture and concentrated in hemozoin. In vitro, hemin and 
artemisinin were found to undergo a chemical reaction forming two major products which were isolated by high- 
performance liquid chromatography (HPLC). The m/z values of the two products were 856 and 871. Thin-layer 
chromatography (TLC) and HPLC of hemozoin isolated from [14C]artemisinin-treated parasites showed that the 
majority of the hemozoin-associated radioactivity comigrated with the synthetic adducts. When [~4C]artemisinin was 
incubated with isolated hemozoin, [~4C]artemisinin disappeared from the solution in a time-dependent manner. Some of 
the radioactivity present in the treated hemozoin also comigrated with the adducts on TLC. Thus, artemisinin appears 
to react covalently with heme in malaria hemozoin both in vitro and in situ. 
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I. Introduction 
Artemisinin, which is derived from an ancient 
Chinese herbal remedy for fever, is a sesquiter- 
pene endoperoxide [1,2]. Several artemisinin deri- 
vatives, especially artemether and artesunate have 
been widely used in Asia, particularly China, 
where over one million patients have been treated 
[3]. In addition, a large number  of  synthetic endo- 
peroxides have been synthesized and found to 
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have antimalarial activity. One of these synthetic 
endoperoxides, Ro. 42-1611, is currently under- 
going Phase II clinical trials (R. Ridley, Hoff- 
man-LaRoche,  personal communication). Thus, 
the artemisinin derivatives represent a promising 
new class of  antimalarial agents. 
Malaria parasites live inside erythrocytes and 
consume hemoglobin. When heme molecules are 
released, they polymerize and accumulate in intra- 
parasitic granules known as malaria pigment or 
hemozoin [4,5]. We have previously proposed 
that this accumulation of heme sensitizes malaria 
parasite to the toxic effects of  artemisinin and its 
derivatives, because it catalyzes the decomposition 
of the drug into free radicals which act as alkylat- 
ing agents [6 9]. In this paper we show that arte- 
misinin concentrates in hemozoin where it is cova- 
122 
lently bound to heine. 
2. Materials and methods 
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2.1. Chemicals. Artemisinin was purchased from 
Aldrich Chemical Company (Milwaukee, WI). 
[14C]Artemisinin (45.5 mCi mmol  l) was a gift 
from the Division of Experimental Therapeutics, 
Walter Reed Army Institute of  Research, Wa- 
shington DC. All other chemicals were purchased 
from Sigma Chemical Co. (St. Louis, MO). 
2.2. Isolation ofl malarial hemozoin. P. falciparum 
FCR3 strain was cultivated by the method of Tra- 
get and Jensen [10]. Hemozoin was isolated from 
these cultures by a modification of the method of 
Goldie et al. [11]. Parasite cultures were pooled 
and the cells were pelleted by centrifugation at 
540 x g. The pellet was washed once with RPMI 
and then lysed by the addition of an equal volume 
of hypotonic buffer (8 mM potassium phosphate/  
9 mM disodium EDTA,  pH 7.2) followed by soni- 
cation with a microprobe at maximum intensity 
for 15 s (Sonifier Cell Disruptor, Heat Systems- 
Ultrasonics, Long island, NY). Crude hemozoin 
was then pelleted by centrifugation at 35 000 × g 
at 4°C for 10 rain. The pellet was resuspended in 
10 ml hypotonic buffer, sonicated and centrifuged 
at least thrice, until the supernatant became color- 
less. The pellet was then resuspended in 1 ml hy- 
potonic buffer and carefully layered on top of 10 
ml of  30% sucrose in hypotonic buffer and centri- 
fuged at 35 000 x g for 1 h at 4°C. The hemozoin, 
at the bot tom of the gradient, was removed, 
washed 3 times with water, resuspended in 1 ml 
1% SDS and centrifuged at 13 000 × g. The pel- 
let and pooled supernatants were stored at 
- 8 0 ° C .  
2.3. Synthesis and partial isolation of hemin\artem- 
isinin adducts. A 10 mM hemin solution was pre- 
pared immediately prior to each experiment by 
first dissolving hemin in 1 N NaOH,  diluting with 
Tris-HC1 buffer (50 mM pH 8.5) and adjusting the 
pH to 8.5 with 1 N HCI. Artemisinin was dis- 
solved in methanol as a 10 mM solution and 
stored at - 2 0 ° C .  Equal volumes of hemin (10 
mM) and artemisinin (10 mM) were mixed and 
incubated in the dark at 37°C for 20 24 h. 
The products of  the reaction were separated by 
using high-performance liquid chromatography 
(HPLC; Rainin Instrument Co. Inc., Woburn,  
MA) with a 300 x 22.5 mm Bondclone C18 semi- 
preparative column (Phenomenex, Torrance, CA) 
and a flow rate of  15 ml min 1 by a modification 
of the methods of Choe and Ortiz de Montellano 
[12]. The column was eluted with a mixture of  
methanol/  water/ acetic acid (32:18:5) and moni- 
tored at 400 nm. Before each injection, 600 #1 of 
the reaction mixture was mixed with 400 /~1 of 
methanol /acet ic  acid (3:1), clarified by centrifuga- 
tion and injected. The products collected from the 
column were concentrated by low pressure distilla- 
tion using a Buchi Rotary Evaporator  (Brink- 
mann Instruments, Inc., Westbury, NY) until al- 
most dry. The products were redissolved in metha- 
nol and rechromatographed by using a mixture of  
me thano l /wa te r / ace t i c  acid (7:3:1) as the elution 
buffer and concentrated as above. Finally the pur- 
ified products were dissolved in methanol and 
stored at - 20:C. 
2.4. Mass spectroscopy. The molecular weights 
of  the isolated reaction products were determined 
by two mass spectroscopic methods. Electrospray 
ionization (ESI) mass spectra were obtained on a 
model 201 single quadrupole mass spectrometer 
(Vestec Corp. Houston, TX), with a 2000 m/z 
range and a Vestec electrospray source. Fast 
atom bombardment  (FAB) ionization mass spec- 
tra was obtained on a model 70-250-S mass spec- 
trometer (VG Analytical, Manchester, England), 
using a fast a tom bombardment  atom gun with a 
current of  I mA and a voltage of 8 kV. Xenon was 
the gas ion source. 
2.5. The reaction of isolated hemozoin and [NC]- 
artemisinin. Hemozoin, which was isolated as 
above from 10 plates of  untreated parasites, was 
incubated with 0.042/tCi [14C]artemisinin in 1 ml 
of 10% methanol and 90% PBS at 37'~C in the 
dark. As a control, 0.042 pCi artemisinin was dis- 
solved in the same solution in the absence of he- 
mozoin. 7 #1 of supernatant were removed at 0, 1, 
2 and 19 h, respectively. 
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2.6. Fate of radioactivity in drug-treated para- 
sites. Hemozoin, which was isolated from 
[xnC]artemisinin-treated parasites or was incu- 
bated with []4C]artemisinin as above, was dis- 
solved in 200-300 /d 0.1 N KOH and then 
precipitated by the addition of  one drop of 1 N 
HC1. After microfuging for 1 rain, the superna- 
tant was discarded and the pellet was redissolved 
in a mixture of methanol/ water/ acetic acid 
(32:18:5). 20 ~tl were spotted onto a C18 reverse- 
phase fluorescence thin-layer chromatography 
(TLC) plate (Whatman International Ltd., Maid- 
stone, England) and developed at room tempara- 
ture with water/acetic acid/methanol (2:1:7). 
Artemisinin, hemin and the artemisinin-heme ad- 
ducts isolated from HPLC were used as standards. 
After each run, the reverse phase plate layer was 
divided into 0.5-cm fractions and scraped into 
scintillation vials. 100 /tl of methanol was added 
to dissolve the drug followed by 10 ml of scintilla- 
tion fluid. The radioactivity was then counted in a 
scintillation counter. 
Alternatively, hemozoin was dissolved in 0.2 N 
KOH, mixed with an equal volume of methanol/ 
acetic acid (9:1) and analyzed by HPLC on a 300 
× 3.9 mm /tBondapak C18 analytical column 
(Waters, Milford MA), eluting at a flow rate of 1 
ml min-1 with methanol/water/acetic acid 
(57:34:9) for 30 min followed by methanol/acetic 
acid (9:1) for 10 min. 
Table 1 
Fate of  radioactivity in [~4Clartemisinin treated parasites a 
Fraction Counts  % Protein % 
rain 1 (mg) 
Pooled supernatants  84635 25 2081.3 99.58 
Hemazoin 
SDS-extract 90665 27 8.3 0.40 
SDS-pellet 165000 48 0.5 0.02 
Total 340300 2090.1 
123 
2.7. Biochemical assays. Protein in each fraction 
was determined by bicinchoninic acid binding [13]. 
Heme was determined by the modified methods of 
Fuhrhop and Smith [14]. Radioactivity was mea- 
sured on an LKB 1219 Rackbeta or a Bechman 
LS 7000 Scintillation counter using Scintivers BD 
scintillation fluid (Fisher Scientific, Fair Lawn, 
N J). 
3. Results 
When malaria parasites were incubated in the 
presence of [t4C]artemisinin, more than 40% of 
the added drug was taken up by the cultures 
(data not shown). Of the cell-associated radioac- 
tivity, only 25% was found in the pooled washes 
~Cultured for 8 h in the presence of  [14C]artemisinin (2.7 nCi 
ml I). 
and gradient, which contained more than 99% of 
the total protein (Table 1). The remainder, 75% of 
the radioactivity, was associated with the isolated 
parasite hemozoin. About 1/3 of the hemozoin- 
associated radioactivity could be extracted with 
1% SDS, which solubilized >9 5 % of the pelleted 
protein (Table 1). The SDS-washed hemozoin pel- 
g 
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Fig. 1. HPLC separat ion of  hemin and artemisinin reaction 
products after incubating 20 h at 37°C in the dark. HPLC was 
performed on a semipreparative column as described in the 
Materials and Methods,  eluting with methanol /  water/ acetic 
acid (7:3:1). (A) Reaction mixture; (B) Rechromatography of 
pooled products from A. 
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let contained the equivalent of  2.3 mmol artemisi- 
nin (tool heme) i. 
In order to understand the interaction of hemin 
and artemisinin, the two compounds were mixed 
and allowed to react in solution. Two reaction 
product peaks were found by HPLC which eluted 
after the heme peak (Fig. 1). These peaks were not 
seen when either reactant was incubated in the 
same buffer but in the absence of the second reac- 
tant (data not shown). The molecular weights of  
the adducts were then determined by ESI and 
FAB mass spectroscopy. Both methods gave 
identical m / z  values for heme (616), adduct A 
(856), and adduct B (871) (Fig. 2). Hemin, artemi- 
sinin and the adducts could also be separated by 
reverse-phase TLC (Fig. 3). [The Rf  of  artemisinin 
856  
A 871, B 
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Fig. 3. TLC of artemisinin, hemin and the isolated hemin/arte- 
misinin adducts visualized by exposure to iodine vapor. 
is 0.41 and the Rf  of  hemin is 0.33. The adducts 
have Rfs of 0.16 and 0.21]. Neither adduct is fluor- 
escent, suggesting that they still contain iron 
atoms (data not shown). Unfortunately, however, 
we were unable to successfuly remove the iron 
from these adducts in order to be able to run 
NMRs. 
TLC and HPLC were then used to determine 
whether these adducts were also formed in vivo. 
The TLC system used could easily distinguish be- 
tween artemisinin, heme and the adducts, 
although not easily between the two adducts (Fig. 
3) When hemozoin was isolated from 
[14C]artemisinin treated parasites and analyzed by 
TLC, 77% of the total radioactivity comigrated 
with the synthetic adducts (Fig. 4). Similar results 
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Fig. 4. Radioactivity profile of  TLC run on hemozoin isolated 
from [~4C]artemisinin-treated parasites. The parasites were cul- 
tured in the presence of [14C]artemisinin (1.8 nCi ml t) for 6 h 
before isolation. Origin of plate on left, solvent front on right. 
not distinguish easily between the two products 
(Fig. 1). 
Artemisinin also reacted with isolated hemo- 
zoin. When [14C]artemisinin and hemozoin were 
incubated together, [14C]artemisinin disappears 
from solution in a time-dependent manner (Fig. 
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Fig. 5. HPLC profile of  purified product A (top) and of radio- 
activity eluted from an HPLC separation of hemozoin isolated 
from [~4C]artemisinin treated parasites (bottom). Parasites were 
exposed to drug as in Table 1 and chromatographed  on an 
analytical column as described in the Materials and Methods. 
Bottom graph shifted to the left by one minute to compensate 
for time delay between UV detector and fraction collector. 
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Fig. 6. Radioactivity in the supernatant during the incubation 
of [14C]artemisinin in the presence (11) and absence (77) of 
isolated hemozoin. 
20% of the hemozoin-associated radioactivity 
which comigrated with the adducts (not shown). 
This is the equivalent of incorporating 0.5 mmol 
of artemisinin per mol of  heine. 
4. Discussion 
Artemisinin is taken up by malaria parasites 
and concentrated in hemozoin, possibly by form- 
ing adducts. In aqueous solution, artemisinin was 
found to react with hemin, yielding two major 
products with molecular weights of 856 and 871. 
Compounds with identical mobilities on TLC and 
HPLC were found in hemozoin, when either 
whole infected red cells of isolated hemozoin was 
incubated with drug. Thus, artemisinin-heme ad- 
ducts appear to form in vivo. 
The data presented here is consistent with a 
two-step mode of  action of artemisinin, in which 
the first step consists of the heme-catalyzed clea- 
vage of the endoperoxide bridge to form a free 
radical and the second step consists of the alkyla- 
tion of  heme and proteins by the drug-derived free 
radical [15] or other transient drug-derived inter- 
mediate [16]. Other evidence consistent with this 
mechanism includes observations that the endo- 
peroxide bridge is necessary for biological activity 
[17,18] and that free radical scavengers and iron 
chelators antagonize the drug [19 21]. The ability 
of heme and iron to catalyze the decomposition of 
artemisinin has been demonstrated by cyclic volta- 
metry [7], by electron paramagnetic resonance 
spectroscopy [8] and by the isolation and charac- 
terization of the decomposition products [16]. Evi- 
dence for alkylation of heme [6] and proteins [9] 
has also been presented previously. This paper is 
the first time that the heme-artemisinin adducts 
have been isolated and partially characterized. 
The synthetic adducts are likely to be identical to 
the products formed when parasites are treated 
with 14C-labeled drug because they coelute on 
both silica TLC and reverse-phase HPLC. The 
importance of this process is underscored by the 
observation that about half of the cell-associated 
radiolabeled drug can be found in SDS-washed, 
protein-free hemozoin. 
In a previous publication, we showed that a 
crude reaction mixture of heme and artemisinin0 
when analyzed by FAB mass spectrometry, gave 
peaks with rn/z values of 840, 868, 886 and 914 
[6]. In contrast, the purified peaks shown here 
give m/z values of 856 and 871 by both ESI and 
FAB mass spectrometry. The differences between 
the two observations may be due to differences in 
the reaction conditions, as well as to the possibility 
that the impure reaction mixture contained com- 
ponents which were not observed by HPLC since 
the eluate was monitored at 400 nm, a wavelength 
which is characteristic of compounds containing 
porphyrin rings [14]. Interestingly the MW of ad- 
duct B, 871, is 18 less than that of the sum of 
artemisinin (282.4) and heme (616.5) suggesting a 
dehydration. 
More artemisinin concentrates in hemozoin ob- 
tained from [14C]artemisinin-treated infected red 
cells (2.3 mmol mol i heme) than by exposing 
isolated hemozoin to the labeled drug (0.5 mmol 
tool i heme). There are two possible reasons for 
this. First, the heine-catalyzed decomposition of 
artemisinin is reductive [16], suggesting that fer- 
rous heme (Fe +2) is more reactive than ferric 
heme (Fe+3). Heme is more likely to be in the 
reduced state in vivo than in solution because of 
the presence of  intracellular reducing agents such 
as glutathione. Second, in vivo, heme may react 
with artemisinin in the brief time period between 
when it is liberated from hemoglobin and poly- 
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merized to hemozoin  [4]. Once incorpora ted  into 
hemozoin,  only the heme molecules on the sur- 
face of the granules are likely to be reactive with 
ar temisinin,  since the i ron a toms of the interior  
molecules may be sequestered by i ron-carboxyla te  
bonds  [5]. 
W h a t  role does the format ion  heme-ar temis in in  
adducts  play in the drug-media ted  killing of  ma- 
laria parasites? The heme-ar temis inin  adduct  is 
not  toxic to in vitro cultures of P. falciparum 
when added to the media [6]. When  parasites are 
grown in resealed red cells conta in ing  an excess of  
heme, they appear  to be protected from artemisi- 
nin,  presumably  because the adducts  form in the 
red cell cytoplasm (unpubl ished results). However,  
the CR strain of P. berghei, which lacks hemozoin,  
is resistant to ar temis inin  [22]. Fur thermore ,  three- 
quarters  of the cell-associated drug winds up in 
hemozoin,  of  which two-thirds (half of  the total) 
remains  even after SDS extraction of protein.  
Thus,  the fo rmat ion  of ar temis in in-heme adducts  
play impor t an t  but  as yet undef ined roles in the 
mode of act ion of this drug. " 
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